Class 564/197 - The compound is acyclic

Subclass of Class 564 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the amino nitrogen containing residue
No. of applications: 26
Last issue date: 01/26/2012

Application No.	Application Title	Issue Date
20120022230	IONIZABLE ISOTOPIC LABELING REAGENTS FOR RELATIVE QUANTIFICATION BY MASS SPECTROMETRY Relative quantification of metabolites by Electrospray Ionization Mass Spectrometry (ESI-MS) requiring a mechanism for simultaneous analysis of multiple analytes in two or more samples. Labeling reagents that are reactive to particular compound classes and differ only i...	01/26/2012
20110196014	METHIONINE ANALOGS AND METHODS OF USING SAME Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfec...	08/11/2011
20110130456	Hair Growth Regulating Agent A hair growth regulating agent containing, as an active ingredient, a compound represented by the following formula (I): [wherein R1 represents a substituted or unsubstituted, linear or branched C2 to C25 alkyl group; a group represented by the following formula (II): (...	06/02/2011
20110124880	COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a ...	05/26/2011
20110117141	METHODS AND COMPOSITIONS COMPRISING NOVEL CATIONIC LIPIDS Provided herein are novel cationic lipids, compositions comprising the cationic lipids, and methods of using the cationic lipids. In some claims, the cationic lipids have cytotoxic activity and can be used alone or in combination with a cytotoxic bioactive compound to k...	05/19/2011
20110118451	COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a ...	05/19/2011
20110092601	LYSINE-SPECIFIC DEMETHYLASE INHIBITORS Polyamine, polyamine/guanidino, and polyamine/biguanide compounds bearing allene, propargyl, cyclopropyl, and other reactive moieties are disclosed. The compounds are useful as irreversible inhibitors of the enzyme lysine-specific demethylase-1 and for the treatment of ...	04/21/2011
20110065904	H3LMN COMPOUND USED AS RADIOACTIVE AGENT FOR TREATMENT OF LIVER CANCER AND MANUFACTURING METHOD THEREOF H₃LMN series compounds used as radioactive agents for treatment of liver cancer and a manufacturing method thereof are revealed. 2-thioethylamine hydrochloride is reacted with triphenylmethanol for protection of thiol to obtain 2-[(triphenylmethyl)thio]ethyla...	03/17/2011
20110053848	PRODRUG COMPRISING A DRUG LINKER CONJUGATE The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising a drug linker conjugate D-L, wherein -D is an amine containing biologically active moiety; and -L is a non-biologically active linker moiety -L¹represented by...	03/03/2011
20110039682	METHOD FOR SYNTHESIZING ONE-DIMENSIONAL HELICAL NANOPOROUS STRUCTURES AND METHOD FOR SYNTHESIZING GLYCINE-DERIVED SURFACTANT FOR SYNTHESIZING HELICAL NANOPOROUS STRUCTURES Disclosed herein are a method for synthesizing one-dimensional helical mesoporous structure, in which a self-assembled structure of a glycine-derived surfactant is used as a template at room temperature to synthesize the one-dimensional helical mesoporous silica structu...	02/17/2011
20110033560	PREPARATION AND A COMPONENT INTENDED TO BE ADDED TO A TOBACCO PRODUCT The present invention relates to the use of a preparation comprising a substance that is capable of binding acetaldehyde, and to the use of a filter that is attached to a tobacco product to reduce tobacco and/or alcohol dependence....	02/10/2011
20100160409	Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use The invention relates to compounds, which are suitable for coupling to pharmaceuticals, in particular biopharmaceuticals, in addition to conjugates from the compounds comprising biomolecules or pharmaceutically active substances. The inventive compounds are highly cross...	06/24/2010
20100095807	SEPARATION REAGENT OF PLATINUM GROUP METAL, METHOD FOR SEPARATING AND RECOVERING PLATINUM GROUP METAL, AND AMIDE-CONTAINING TERTIARY AMINE COMPOUND The present invention provides a novel separation reagent capable of obtaining a high extraction % of rhodium in a chlorine-based acid solution, which has never existed heretofore, and a method for separating and recovering a platinum group metal using the same. An orga...	04/22/2010
20100094054	COMPOSITION FOR EXTERNAL APPLICATION TO SKIN The present invention provides a composition for external application to skin containing one type or two or more types of compounds selected from the group consisting of aminoacetoamide compounds represented by the following general formula (1) and salts thereof.	04/15/2010
20100068139	Methods of radiofluorination of biologically active vectors The invention relates to conjugates of formula (V) or (VI): wherein X is —CO—NH—, —NH—, —O—, —NHCONH—, or —NHCSNH—; their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes. 03/18/2010
20100035274	Methods for Detecting Symmetrical Dimethylarginine Method of detecting Symmetrical dimethyl arginine (SDMA) in biological samples. SDMA analogs for generating anti-SDMA antibodies having little or no cross-reactivity with asymmetrical dimethyl arginine, arginine, and monomethylarginine. The analogs have a protected or f...	02/11/2010
20090312577	Process for Production of Beta-Amino-Alpha-Hydroxy Carbonxamide Derivative Provided is a process for production of a β-amino-α-hydroxy carboxamide derivative that is important in production of drugs or the like. In the presence of a predetermined solvent, a β-(N-protected)amino-α-hydroxycarboxylic acid is reacted with an amine to conversio...	12/17/2009
20090227522	Targeted Delivery of Pharmaceutical Compounds Techniques are provided for targeting a pharmaceutically active compound using, as a carrier, a molecule (or molecules) having greater affinity for a particular site in a living organism's body than for other sites therein. A compound of the formula B-L-A is provided, w...	09/10/2009
20090124832	OLIGOAMINE COMPOUNDS AND DERIVATIVES THEREOF FOR CANCER THERAPY Oligoamine compounds with anti-cancer and anti-proliferative activity are provided, as well as methods for making and using the compounds. The compounds are shown to be active against prostate cancer cell lines and against prostate cancer tumors in mice. The compounds a...	05/14/2009
20090042997	FLUOROALKYL ACID AMIDE SURFACTANTS Compounds of formula (I) and formula (III): wherein A is ...	02/12/2009
20080317839	AMINO ACID LIPIDS AND USES THEREOF This disclosure provides a range of amino acid lipid compounds and compositions useful for drug delivery, therapeutics, and the diagnosis and treatment of diseases and conditions. The amino acid lipid compounds and compositions can be used for delivery of various agents...	12/25/2008
20080268138	Metal plating compositions and methods Disclosed are metal plating compositions and methods. The metal plating compositions provide good leveling performance and throwing power....	10/30/2008
20080249182	Crystalline Modification of N-Ethyl-2,2-Dichloro-1-Methylcyclopropane-Carboxamide-2-(2,6-Dichloro-Alpha, Alpha, Alpha-Trifluoro-P-Tolyl)Hydrazone The present invention relates to a novel crystalline modification of N-ethyl-2,2-dichloro-1-methylcyclopropane-carboxamide-2-(2,6-dichloro-α,α,α-trifluoro-p-tolyl)hydrazone, to a process for its preparation and to its use for combating pests and parasites. Further, t...	10/09/2008
20080207776	HIGHLY PACKED POLYCATIONIC AMMONIUM, SULFONIUM AND PHOSPHONIUM LIPIDS The present invention discloses highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transformati...	08/28/2008
20080125350	BRANCHED POLYALKYLENE GLYCOLS The present invention provides a branched polyalkylene glycol wherein three or more single-chain polyalkylene glycols and a group having reactivity with an amino acid side chain, the N-terminal amino group or the C-terminal carboxyl group in a polypeptide or a group con...	05/29/2008
20080067123	Substrates With Modified Carbon Surfaces A process for functionalizing a carbon surface and the product thereof is disclosed. The first reactant used contains one or more electron withdrawing groups that thereafter can be reacted with other compounds. The reaction product has enhanced dispersability, interacti...	03/20/2008

PatentStorm

Bizarre Patents

PatentStorm News

Class 564/197 - The compound is acyclic